Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity

Thrombosis Research

Volumn 102, Issue 1, 2001, Pages 61-69

  Ugwu, Francisca ^a   Lemmens, Gudule ^a   Collen, Désiré ^a   Lijnen, H Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Fibrinolysis; Fibroblasts; Gene deficient mice; Matrix metalloproteinases; Plasmin(ogen); Smooth muscle cells

Indexed keywords

ANGIOSTATIN; COLLAGEN; FIBRIN; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; PLASMIN; PLASMINOGEN; STROMELYSIN; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME MODIFICATION; FIBRINOLYSIS; FIBROBLAST; GENOTYPE; KRINGLE DOMAIN; MATRIX METALLOPROTEINASE DEFICIENCY; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SMOOTH MUSCLE FIBER;

ANIMALS; CELLS, CULTURED; CHEMOTAXIS; FIBRINOLYSIS; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH; PLASMINOGEN; URINARY PLASMINOGEN ACTIVATOR; WOUNDS AND INJURIES;

EID: 0035311545     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00218-3     Document Type: Article

References (39)

1. Metalloproteinases and their inhibitors in matrix remodeling
2. Proteolytic remodeling of extracellular matrix
3. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
4. Extracellular proteolysis and the migrating vascular smooth muscle cell
5. Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems
6. Matrix metalloproteinases and their inhibitors
7. Matrix metalloproteinase system deficiencies and matrix degradation
8. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)
9. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3)
10. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3)
11. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
12. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
13. Characterization of stromelysin-1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments
14. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice
15. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes
16. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9
17. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration
18. Urokinase-generated plasmin is a candidate activator of matrix metalloproteinases during atherosclerotic aneurysm formation
19. Temporal and topographic matrix metalloproteinase expression after vascular injury in mice
20. 2-antiplasmin and fibrin
21. Characterization of the murine plasminogen/urokinase-type plasminogen activator system
22. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator
23. Protein and cell membrane iodinations with a sparingly soluble chloroamide,1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
24. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice
25. Screening panels of monoclonal antibodies using phage-displayed antigen
26. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice
27. Plasminogen-dependent and-independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes
28. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
29. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells
30. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat
31. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery
32. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury
33. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury
34. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor
35. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation
36. A metalloproteinase inhibitor (Ro 31-9790) inhibits smooth muscle cell proliferation and migration and neointima formation in human saphenous vein
37. Tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) impairs arterial neointima formation after vascular injury in mice
38. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury